Management of overactive bladder

被引:33
作者
Gulur, Dev M. [2 ]
Drake, Marcus J. [1 ]
机构
[1] Southmead Hosp, Dept Urol, Bristol Urol Inst, Bristol BS10 5NB, Avon, England
[2] Royal Liverpool Univ Hosp, Liverpool L3 5PS, Merseyside, England
关键词
LOWER URINARY-TRACT; NERVE GROWTH-FACTOR; RANDOMIZED CONTROLLED-TRIALS; DETRUSOR WALL THICKNESS; BOTULINUM-TOXIN-A; QUALITY-OF-LIFE; INTERNATIONAL CONSULTATION; SACRAL NEUROMODULATION; ANTICHOLINERGIC DRUGS; INTERSTITIAL-CELLS;
D O I
10.1038/nrurol.2010.147
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Many people are affected by urinary urgency, which can be highly bothersome. Urgency is the cornerstone symptom of overactive bladder (OAB), commonly occurring in conjunction with urinary frequency and nocturia. Once other medical causes of similar symptoms have been excluded, first-line OAB management comprises fluid intake advice and bladder training, supplemented by antimuscarinic drugs if necessary. Urodynamic confirmation of the diagnosis is required for OAB patients whose symptoms are refractory to first-line interventions. If patients are severely bothered by OAB despite optimization of medical treatment, they may proceed to invasive treatments, including neuromodulation, enterocystoplasty, detrusor myectomy, or urinary diversion. Our burgeoning understanding of the complex cellular, neural and integrative physiology of the bladder offers new insights into the causative mechanisms of OAB, and reasons why patients sometimes fail to respond to treatment. Study of sensory information pathways in the lower urinary tract has led to identification of the urothelium, afferent nerves and interstitial cells as key cellular elements in OAB. In-depth knowledge of the hierarchy of central nervous system control is lacking, but functional imaging is beginning to elucidate the challenges that lie ahead. New treatments under investigation include botulinum neurotoxin-A injection, oral beta(3)-adrenergic agonists, and novel modalities for nerve stimulation. The subjective nature of urinary urgency, the lack of animal models and the multifactorial pathophysiology of OAB present significant challenges to effective clinical management.
引用
收藏
页码:572 / 582
页数:11
相关论文
共 109 条
[21]   Drug Insight: biological effects of botulinum toxin A in the lower urinary tract [J].
Chancellor, Michael B. ;
Fowler, Clare J. ;
Apostolidis, Apostolos ;
de Groat, William C. ;
Smith, Christopher P. ;
Somogyi, George T. ;
Aoki, K. Roger .
NATURE CLINICAL PRACTICE UROLOGY, 2008, 5 (06) :319-328
[22]   Surgery for detrusor overactivity [J].
Chapple, CR ;
Bryan, NP .
WORLD JOURNAL OF UROLOGY, 1998, 16 (04) :268-273
[23]   GRC-6211, a New Oral Specific TRPV1 Antagonist, Decreases Bladder Overactivity and Noxious Bladder Input in Cystitis Animal Models [J].
Charrua, Ana ;
Cruz, Celia D. ;
Narayanan, Shridhar ;
Gharat, Laxmikant ;
Gullapalli, Srinivas ;
Cruz, Francisco ;
Avelino, Antonio .
JOURNAL OF UROLOGY, 2009, 181 (01) :379-386
[24]   Transabdominal ultrasonography of detrusor wall thickness in women with overactive bladder [J].
Chung, Shiu-Dong ;
Chiu, Bin ;
Kuo, Hann-Chorng ;
Chuang, Yao-Chi ;
Wang, Chung-Cheng ;
Guan, Zhonghong ;
Chancellor, Michael B. .
BJU INTERNATIONAL, 2010, 105 (05) :668-672
[25]   P2X2 knockout mice and P2X2/P2X3 double knockout mice reveal a role for the P2X2 receptor subunit in mediating multiple sensory effects of ATP [J].
Cockayne, DA ;
Dunn, PM ;
Zhong, Y ;
Rong, WF ;
Hamilton, SG ;
Knight, GE ;
Ruan, HZ ;
Ma, B ;
Yip, P ;
Nunn, P ;
McMahon, SB ;
Burnstock, G ;
Ford, APDW .
JOURNAL OF PHYSIOLOGY-LONDON, 2005, 567 (02) :621-639
[26]   The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study [J].
Coyne, Karin S. ;
Sexton, Chris C. ;
Irwin, Debra E. ;
Kopp, Zoe S. ;
Kelleher, Con J. ;
Milsom, Ian .
BJU INTERNATIONAL, 2008, 101 (11) :1388-1395
[27]   Persistence, adherence, and switch rates among extended-release and immediate-release overactive bladder medications in a regional managed care plan [J].
D'Souza, Anna O. ;
Smith, Michael J. ;
Miller, Lesley-Ann ;
Doyle, Joseph ;
Ariely, Rinat .
JOURNAL OF MANAGED CARE PHARMACY, 2008, 14 (03) :291-301
[28]   The association of diet and other lifestyle factors with the onset of overactive bladder: a longitudinal study in men [J].
Dallosso, HM ;
Matthews, RJ ;
McGrother, CW ;
Donaldson, MMK ;
Shaw, C .
PUBLIC HEALTH NUTRITION, 2004, 7 (07) :885-891
[29]   Nutrient composition of the diet and the development of overactive bladder: A longitudinal study in women [J].
Dallosso, HM ;
McGrother, CW ;
Matthews, RJ ;
Donaldson, MMK .
NEUROUROLOGY AND URODYNAMICS, 2004, 23 (03) :204-210
[30]   A neurologic basis for the overactive bladder [J].
de Groat, WC .
UROLOGY, 1997, 50 (6A) :36-52